85 related articles for article (PubMed ID: 11090074)
1. A carboxy-terminal domain of ELL is required and sufficient for immortalization of myeloid progenitors by MLL-ELL.
DiMartino JF; Miller T; Ayton PM; Landewe T; Hess JL; Cleary ML; Shilatifard A
Blood; 2000 Dec; 96(12):3887-93. PubMed ID: 11090074
[TBL] [Abstract][Full Text] [Related]
2. MLL-AFX requires the transcriptional effector domains of AFX to transform myeloid progenitors and transdominantly interfere with forkhead protein function.
So CW; Cleary ML
Mol Cell Biol; 2002 Sep; 22(18):6542-52. PubMed ID: 12192052
[TBL] [Abstract][Full Text] [Related]
3. The PHD fingers of MLL block MLL fusion protein-mediated transformation.
Muntean AG; Giannola D; Udager AM; Hess JL
Blood; 2008 Dec; 112(12):4690-3. PubMed ID: 18796627
[TBL] [Abstract][Full Text] [Related]
4. Proteolytic cleavage of MLL generates a complex of N- and C-terminal fragments that confers protein stability and subnuclear localization.
Hsieh JJ; Ernst P; Erdjument-Bromage H; Tempst P; Korsmeyer SJ
Mol Cell Biol; 2003 Jan; 23(1):186-94. PubMed ID: 12482972
[TBL] [Abstract][Full Text] [Related]
5. MLL, a mammalian trithorax-group gene, functions as a transcriptional maintenance factor in morphogenesis.
Yu BD; Hanson RD; Hess JL; Horning SE; Korsmeyer SJ
Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10632-6. PubMed ID: 9724755
[TBL] [Abstract][Full Text] [Related]
6. MLL-ENL cooperates with SCF to transform primary avian multipotent cells.
Schulte CE; von Lindern M; Steinlein P; Beug H; Wiedemann LM
EMBO J; 2002 Aug; 21(16):4297-306. PubMed ID: 12169632
[TBL] [Abstract][Full Text] [Related]
7. Myeloid transformation by
Wesolowski R; Kowenz-Leutz E; Zimmermann K; Dörr D; Hofstätter M; Slany RK; Mildner A; Leutz A
Life Sci Alliance; 2021 Jan; 4(1):. PubMed ID: 33144337
[TBL] [Abstract][Full Text] [Related]
8. MLL associates specifically with a subset of transcriptionally active target genes.
Milne TA; Dou Y; Martin ME; Brock HW; Roeder RG; Hess JL
Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14765-70. PubMed ID: 16199523
[TBL] [Abstract][Full Text] [Related]
9. HOXA9 promotes MYC-mediated leukemogenesis by maintaining gene expression for multiple anti-apoptotic pathways.
Miyamoto R; Kanai A; Okuda H; Komata Y; Takahashi S; Matsui H; Inaba T; Yokoyama A
Elife; 2021 Jul; 10():. PubMed ID: 34310280
[TBL] [Abstract][Full Text] [Related]
10. The DN2 Myeloid-T (DN2mt) Progenitor is a Target Cell for Leukemic Transformation by the TLX1 Oncogene.
Zweier-Renn LA; Riz I; Hawley TS; Hawley RG
J Bone Marrow Res; 2013 Feb; 1():. PubMed ID: 25309961
[TBL] [Abstract][Full Text] [Related]
11. Critical role of the platelet-derived growth factor receptor (PDGFR) beta transmembrane domain in the TEL-PDGFRbeta cytosolic oncoprotein.
Toffalini F; Hellberg C; Demoulin JB
J Biol Chem; 2010 Apr; 285(16):12268-78. PubMed ID: 20164181
[TBL] [Abstract][Full Text] [Related]
12. Zebrafish ELL-associated factors Eaf1/2 modulate erythropoiesis via regulating gata1a expression and WNT signaling to facilitate hypoxia tolerance.
Liu W; Lin S; Li L; Tai Z; Liu JX
Cell Regen; 2023 Apr; 12(1):10. PubMed ID: 37002435
[TBL] [Abstract][Full Text] [Related]
13. Sequence, structural and functional conservation among the human and fission yeast ELL and EAF transcription elongation factors.
Sweta K; Dabas P; Sharma N
Mol Biol Rep; 2022 Feb; 49(2):1303-1320. PubMed ID: 34807377
[TBL] [Abstract][Full Text] [Related]
14. HBO1-MLL interaction promotes AF4/ENL/P-TEFb-mediated leukemogenesis.
Takahashi S; Kanai A; Okuda H; Miyamoto R; Komata Y; Kawamura T; Matsui H; Inaba T; Takaori-Kondo A; Yokoyama A
Elife; 2021 Aug; 10():. PubMed ID: 34431785
[TBL] [Abstract][Full Text] [Related]
15. Rare
Panagopoulos I; Andersen K; Eilert-Olsen M; Rognlien AG; Munthe-Kaas MC; Micci F; Heim S
Cancer Genomics Proteomics; 2021; 18(2):121-131. PubMed ID: 33608309
[TBL] [Abstract][Full Text] [Related]
16. A higher-order configuration of the heterodimeric DOT1L-AF10 coiled-coil domains potentiates their leukemogenenic activity.
Song X; Yang L; Wang M; Gu Y; Ye B; Fan Z; Xu RM; Yang N
Proc Natl Acad Sci U S A; 2019 Oct; 116(40):19917-19923. PubMed ID: 31527241
[TBL] [Abstract][Full Text] [Related]
17. Rare myeloid sarcoma with KMT2A (MLL)-ELL fusion presenting as a vaginal wall mass.
Bao H; Gao J; Chen YH; Altman JK; Frankfurt O; Wilson AL; Sukhanova M; Chen Q; Lu X
Diagn Pathol; 2019 Mar; 14(1):26. PubMed ID: 30922345
[TBL] [Abstract][Full Text] [Related]
18. RNA Polymerase II-Dependent Transcription Initiated by Selectivity Factor 1: A Central Mechanism Used by MLL Fusion Proteins in Leukemic Transformation.
Yokoyama A
Front Genet; 2018; 9():722. PubMed ID: 30693017
[TBL] [Abstract][Full Text] [Related]
19. Murine Retrovirally-Transduced Bone Marrow Engraftment Models of MLL-Fusion-Driven Acute Myelogenous Leukemias (AML).
Stubbs MC; Krivtsov AV
Curr Protoc Pharmacol; 2017 Sep; 78():14.42.1-14.42.19. PubMed ID: 28892146
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
